NEW YORK, NY / ACCESS Newswire / November 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ:ALEC) concerning possible violations of federal securities laws. On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with […]
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=175101&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=175106&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Lantheus Holdings, Inc. (NASDAQ:LNTH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lantheus-holdings-inc-lawsuit-submission-form-2?prid=175109&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Akebia Therapeutics, Inc. ("Akebia Therapeutics, Inc.") (NASDAQ:AKBA) concerning possible violations of federal securities laws. On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fly-e-group-inc-lawsuit-submission-form?prid=175111&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=175110&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ:TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug,
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=175115&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Fluor Corporation (NYSE:FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=175114&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call